Minimal Residual Disease in Acute Lymphoblastic Leukemia
1 Vues
administrator
06/15/23
The panelists, Raoul Tibes, MD, PhD; Stefan Faderl, MD; and Bijal D. Shah, MD, outline methods of measuring minimal residual disease and its role in the management of acute lymphoblastic leukemia.
Montre plus
Commentaires de Facebook
Aucun commentaire trouvé